The 2024 Stanford Drug Discovery Symposium (2024 SDDS) is coming up on April 29-30,
旧金山湾区的小伙伴有福了 2024 SDDS on April 29-30
版主: Tlexander
-
- 论坛点评
- 帖子: 2995
- 注册时间: 7月 22, 2022, 5:34 pm
#2 Re: 旧金山湾区的小伙伴有福了 2024 SDDS on April 29-30
George Addona, PhD - Senior VP and Head of Discovery, Preclinical Development, and Translational Medicine, Merck
Sharon Barr, PhD - SVP Biotherapeutics R&D, AstraZeneca
Hal Barron, MD - CEO and Founder, Atlas Labs
Carolyn Bertozzi, PhD - Anne T. and Robert M. Bass Professor, Stanford University
Paul Biondi, MBA - Executive Partner and President of Pioneering Medicine, Flagship Pioneering
Catherine Boileau, PhD, PharmD - Emeritus Professor of Genetics, Medical School of Paris Cité University
Paul Burton, MD, PhD - Chief Medical Officer, Amgen
Rob Califf, MD - Commissioner of Food and Drugs, FDA
Rosa Canet-Avilés, PhD - Vice President, Scientific Programs & Education, CIRM
Patrizia Cavazzoni, MD - Director of the Center for Drug Evaluation and Research (CDER), FDA
Don Cleveland, PhD - Department Chair and Professor, Cellular and Molecular Medicine, UCSJ
Marianne De Backer, M.Sc., MBA, MD - CEO and Director, VIR Biotechnology
Michael Devoy, MD - CMO of Bayer and EVP Medical Affairs & Pharmacovigilance for the Pharmaceuticals Division, Bayer
Paulo Fontoura, MD, PhD - Global Head and SVP of Neuroscience, Immunology, Ophthalmology, and Rare Diseases, Roche
Julie Grant, MBA, MPhil - General Partner, Canaan
Aida Habtezion, MD - CMO and Head of Worldwide Medical & Safety, Pfizer
Helen Hobbs, MD - Philip O'Bryan Montgomery Jr., MD, Distinguished Chair in Developmental Biology; Eugene McDermott Distinguished Chair for the Study of Human Growth and Development, UT Southwestern Medical Center
Karin Immergluck, PhD - Director, Stanford Office of Technology and Licensing
Joe Jimenez, MBA - Co-Founder and Managing Director, Arturine Bio
Karin Kleinhans, MSc, PhD - Partner, Life Ventures Fund
Hallie Kuhn, PhD - Senior Vice President, Alexandria Venture Investments
Michelle Longmire, MD - Co-Founder and CEO, Medable, Inc.
Thomas Lynch, MD - President and Director, Fred Hutchinson Cancer Research Center
Fady Malik, MD, PhD - Executive Vice President of Research & Development, Cytokineticss
Mathai Mammen, MD, PhD - CED, President, and Chairman, FogPharma
Peter Marks, MD, PhD - Director, Center for Biologics Evaluation and Research (CBER), FDA
Flavius Martin, MD - Executive Vice President of Research, Gilead Sciences
Lloyd Minor, MD - Carl and Elizabeth Naumann Professor and Vice Dean for Education, Stanford School of Medicine
Deep Nishar, MBA - Managing Director, General Catalyst
Yevgeniya Nusinovich, MD, PhD - Science Editor, Science Magazine
Robert Plenge, MD, PhD - Executive Vice President, Chief Research Officer, Head of Research Bristol Myers Squibb
Joni Rutter, PhD - Director, National Center for Advancing Translational Sciences (NCATS), NIH
Camille Samuels, MBA - Partner, Venrock
Wade Shen - Director of Proactive Health Office, APHA-H
Abhishek Shukla - Managing Director, Prosperity7Ventures
Daniel Skovronsky, MD, PhD - CSO and President, Lilly Research Labs; President, Immunology, Eli Lilly and Co.
Andrew Trister, MD, PhD - CMO and CSO, Verily Life Sciences
Andrea van Elsas, PhD - Partner, Third Rock Ventures
Gregory Verdine, PhD - Erving Professor of Chemistry, Harvard University
Michelle Williams, ScD - Dean and Mallinckrodt Professor of Epidemiology and Public Health, Harvard University
Bei Zhang, PhD - Corporate Vice President, Novo Nordisk
Sharon Barr, PhD - SVP Biotherapeutics R&D, AstraZeneca
Hal Barron, MD - CEO and Founder, Atlas Labs
Carolyn Bertozzi, PhD - Anne T. and Robert M. Bass Professor, Stanford University
Paul Biondi, MBA - Executive Partner and President of Pioneering Medicine, Flagship Pioneering
Catherine Boileau, PhD, PharmD - Emeritus Professor of Genetics, Medical School of Paris Cité University
Paul Burton, MD, PhD - Chief Medical Officer, Amgen
Rob Califf, MD - Commissioner of Food and Drugs, FDA
Rosa Canet-Avilés, PhD - Vice President, Scientific Programs & Education, CIRM
Patrizia Cavazzoni, MD - Director of the Center for Drug Evaluation and Research (CDER), FDA
Don Cleveland, PhD - Department Chair and Professor, Cellular and Molecular Medicine, UCSJ
Marianne De Backer, M.Sc., MBA, MD - CEO and Director, VIR Biotechnology
Michael Devoy, MD - CMO of Bayer and EVP Medical Affairs & Pharmacovigilance for the Pharmaceuticals Division, Bayer
Paulo Fontoura, MD, PhD - Global Head and SVP of Neuroscience, Immunology, Ophthalmology, and Rare Diseases, Roche
Julie Grant, MBA, MPhil - General Partner, Canaan
Aida Habtezion, MD - CMO and Head of Worldwide Medical & Safety, Pfizer
Helen Hobbs, MD - Philip O'Bryan Montgomery Jr., MD, Distinguished Chair in Developmental Biology; Eugene McDermott Distinguished Chair for the Study of Human Growth and Development, UT Southwestern Medical Center
Karin Immergluck, PhD - Director, Stanford Office of Technology and Licensing
Joe Jimenez, MBA - Co-Founder and Managing Director, Arturine Bio
Karin Kleinhans, MSc, PhD - Partner, Life Ventures Fund
Hallie Kuhn, PhD - Senior Vice President, Alexandria Venture Investments
Michelle Longmire, MD - Co-Founder and CEO, Medable, Inc.
Thomas Lynch, MD - President and Director, Fred Hutchinson Cancer Research Center
Fady Malik, MD, PhD - Executive Vice President of Research & Development, Cytokineticss
Mathai Mammen, MD, PhD - CED, President, and Chairman, FogPharma
Peter Marks, MD, PhD - Director, Center for Biologics Evaluation and Research (CBER), FDA
Flavius Martin, MD - Executive Vice President of Research, Gilead Sciences
Lloyd Minor, MD - Carl and Elizabeth Naumann Professor and Vice Dean for Education, Stanford School of Medicine
Deep Nishar, MBA - Managing Director, General Catalyst
Yevgeniya Nusinovich, MD, PhD - Science Editor, Science Magazine
Robert Plenge, MD, PhD - Executive Vice President, Chief Research Officer, Head of Research Bristol Myers Squibb
Joni Rutter, PhD - Director, National Center for Advancing Translational Sciences (NCATS), NIH
Camille Samuels, MBA - Partner, Venrock
Wade Shen - Director of Proactive Health Office, APHA-H
Abhishek Shukla - Managing Director, Prosperity7Ventures
Daniel Skovronsky, MD, PhD - CSO and President, Lilly Research Labs; President, Immunology, Eli Lilly and Co.
Andrew Trister, MD, PhD - CMO and CSO, Verily Life Sciences
Andrea van Elsas, PhD - Partner, Third Rock Ventures
Gregory Verdine, PhD - Erving Professor of Chemistry, Harvard University
Michelle Williams, ScD - Dean and Mallinckrodt Professor of Epidemiology and Public Health, Harvard University
Bei Zhang, PhD - Corporate Vice President, Novo Nordisk